Last reviewed · How we verify

NCT04781569: PROSA

Staphylococcus Aureus Caught in Action at the Site of Infection

Completed Last updated 3 June 2021
What this trial tests

trial testing data collection in Staphylococcus (S.) Aureus Infection in 100 participants. Completed in 23 November 2020.

Timeline
6 June 2017
Primary endpoint
23 November 2020
23 November 2020

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date6 June 2017
Primary completion23 November 2020
Estimated completion23 November 2020
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

18 and older, any sex, with Staphylococcus (S.) Aureus Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to obtain a comprehensive view of S. aureus adaptations in the infected human host and (i) to improve the understanding of the interface between antibiotic therapy, resistance development and virulence factor adaptation in S. aureus infected patients, and (ii) to adapt these findings into a more sustainable use of antimicrobials for therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of data collection

Trials testing the same drug.

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04781569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing